T2 Biosystems Release: Clinical Chemistry Study Reports On Use Of T2MR To Evaluate Hemostasis In Whole Blood

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems today announced that scientists from the University of Pennsylvania and T2 Biosystems have published a manuscript in Clinical Chemistry evaluating the use of T2MR technology for studying comprehensive hemostasis in whole blood. Titled “T2 magnetic resonance: a diagnostic platform for studying integrated hemostasis in whole blood – proof of concept,” the publication explores the potential of T2MR, an innovative and proprietary magnetic resonance-based diagnostic technology platform that may offer a rapid, sensitive and simple alternative to the current clinical standard in diagnostics.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC